Aktieanalys

XVIVO Q2: A roaring quarter - Redeye

Redeye Publicerad: 12 Jul 08:26

XVIVO delivered a positive surprise in Q2 with organic growth of 35% which was well ahead of the already improved earlier quarter, Redeye’s expectations and the market expectations. Possibly also ahead of XVIVO’s expectations. The overall gross margin was a healthy 75% and EBITDA was a substantial positive surprise. This is even more reassuring as XVIVO will improve its structural support gradually after Q3 2024 in our view. We expect a substantial share price reaction and XVIVO is well placed ahead of 2025.

Länk till analysen i sin helhet: https://www.redeye.se/research/1021482/xvivo-q2-a-roaring-quarter?utm_source=finwire&utm_medium=RSS

Nyheter om Xvivo Perfusion

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!